Streptococcus pneumoniae bacteria are common inhabitants of the respiratory tract and can cause various diseases, including otitis media, sinusitis, and pneumonia. S. pneumoniae bacteria also cause invasive pneumococcal disease, especially in high-risk groups, and vaccines are regarded as the most effective method for preventing pneumococcal infection. The pneumococcal vaccines currently available in Taiwan are PPV 23, which is a pneumococcal polysaccharide vaccine, and PCV13 and PCV15, which are pneumococcal conjugate vaccines. High-risk groups should follow the vaccine recommendations of the Taiwan Centers for Disease Control to obtain protection from pneumococcal infections. S. pneumoniae is the most identified pathogen in patients with secondary bacterial infection following a primary influenza virus infection. Consequently, annual influenza vaccination is crucial for preventing pneumococcal infections.